BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22800301)

  • 1. The positional specificity of EXXK motifs within an amphipathic α-helix dictates preferential lysine modification by acrolein: implications for the design of high-density lipoprotein mimetic peptides.
    Zheng Y; Kim SH; Patel AB; Narayanaswami V; Iavarone AT; Hura GL; Bielicki JK
    Biochemistry; 2012 Aug; 51(32):6400-12. PubMed ID: 22800301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
    Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW
    J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of α-helical structure by HDL mimetic peptide ATI-5261 upon extensive dilution represents an important determinant for stimulating ABCA1 cholesterol efflux with high efficiency.
    Zheng Y; Patel AB; Narayanaswami V; Bielicki JK
    Biochem Biophys Res Commun; 2013 Nov; 441(1):71-6. PubMed ID: 24129191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.
    Tran TN; Kosaraju MG; Tamamizu-Kato S; Akintunde O; Zheng Y; Bielicki JK; Pinkerton K; Uchida K; Lee YY; Narayanaswami V
    Biochemistry; 2014 Jan; 53(2):361-75. PubMed ID: 24325674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
    Hafiane A; Bielicki JK; Johansson JO; Genest J
    PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein.
    Bergt C; Fu X; Huq NP; Kao J; Heinecke JW
    J Biol Chem; 2004 Feb; 279(9):7856-66. PubMed ID: 14660678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
    Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
    Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols.
    Furuhata A; Nakamura M; Osawa T; Uchida K
    J Biol Chem; 2002 Aug; 277(31):27919-26. PubMed ID: 12032148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins.
    Vedhachalam C; Narayanaswami V; Neto N; Forte TM; Phillips MC; Lund-Katz S; Bielicki JK
    Biochemistry; 2007 Mar; 46(10):2583-93. PubMed ID: 17305370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.
    D'Souza W; Stonik JA; Murphy A; Demosky SJ; Sethi AA; Moore XL; Chin-Dusting J; Remaley AT; Sviridov D
    Circ Res; 2010 Jul; 107(2):217-27. PubMed ID: 20508181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein modification by acrolein: formation and stability of cysteine adducts.
    Cai J; Bhatnagar A; Pierce WM
    Chem Res Toxicol; 2009 Apr; 22(4):708-16. PubMed ID: 19231900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrolein modifies apolipoprotein A-I in the human artery wall.
    Shao B; O'brien KD; McDonald TO; Fu X; Oram JF; Uchida K; Heinecke JW
    Ann N Y Acad Sci; 2005 Jun; 1043():396-403. PubMed ID: 16037261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice.
    Bielicki JK; Zhang H; Cortez Y; Zheng Y; Narayanaswami V; Patel A; Johansson J; Azhar S
    J Lipid Res; 2010 Jun; 51(6):1496-503. PubMed ID: 20075422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution.
    Zheng Y; Patel AB; Narayanaswami V; Hura GL; Hang B; Bielicki JK
    Biochemistry; 2011 May; 50(19):4068-76. PubMed ID: 21476522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody against protein-bound glutathione: use of glutathione conjugate of acrolein-modified proteins as an immunogen.
    Furuhata A; Honda K; Shibata T; Chikazawa M; Kawai Y; Shibata N; Uchida K
    Chem Res Toxicol; 2012 Jul; 25(7):1393-401. PubMed ID: 22716076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter.
    Sviridov DO; Ikpot IZ; Stonik J; Drake SK; Amar M; Osei-Hwedieh DO; Piszczek G; Turner S; Remaley AT
    Biochem Biophys Res Commun; 2011 Jul; 410(3):446-51. PubMed ID: 21672528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in lysine adduction by acrolein and methyl vinyl ketone: implications for cytotoxicity in cultured hepatocytes.
    Kaminskas LM; Pyke SM; Burcham PC
    Chem Res Toxicol; 2005 Nov; 18(11):1627-33. PubMed ID: 16300370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.